Axon Enterprise - AXON Stock Forecast, Price & News

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. StockNews.com upgraded Axon Enterprise from a "hold" rating to a "buy" rating in a research report on Saturday, June 18th. Morgan Stanley downgraded Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 target price for the company. in a research report on Monday, May 23rd. Northland Securities dropped their target price on Axon Enterprise from $180.00 to $130.00 in a research report on Thursday, May 12th. JMP Securities restated a "buy" rating and set a $195.00 target price on shares of Axon Enterprise in a research report on Wednesday, June 1st. Finally, Credit Suisse Group dropped their target price on Axon Enterprise from $169.00 to $134.00 in a research report on Thursday, July 14th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $162.25.

Axon Enterprise Stock Down 1.0 %

Shares of AXON Stock traded down $1.20 on Tuesday, hitting $115.03. 611 shares of the stock were exchanged, compared to its average volume of 263,886. The company has a current ratio of 2.43, a quick ratio of 2.18 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $8.17 billion, a P/E ratio of 223.52 and a beta of 0.66. The business has a 50-day moving average of $96.81 and a 200 day moving average of $112.82. Axon Enterprise has a fifty-two week low of $82.49 and a fifty-two week high of $209.00.

Axon Enterprise (NASDAQ:AXON - Get Rating) last posted its quarterly earnings data on Tuesday, May 10th. The biotechnology company reported $0.76 earnings per share for the quarter. Axon Enterprise had a return on equity of 3.90% and a net margin of 4.62%. The company had revenue of $256.43 million during the quarter, compared to analysts' expectations of $233.57 million. During the same period in the prior year, the firm earned ($0.75) earnings per share. Axon Enterprise's revenue for the quarter was up 31.5% compared to the same quarter last year. Equities analysts anticipate that Axon Enterprise will post 1.35 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Mark W. Kroll sold 3,159 shares of the company's stock in a transaction that occurred on Wednesday, June 8th. The stock was sold at an average price of $102.82, for a total value of $324,808.38. Following the sale, the director now owns 13,691 shares in the company, valued at $1,407,708.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 6.90% of the company's stock.